These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 26604281)

  • 1. Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis.
    Gorst C; Kwok CS; Aslam S; Buchan I; Kontopantelis E; Myint PK; Heatlie G; Loke Y; Rutter MK; Mamas MA
    Diabetes Care; 2015 Dec; 38(12):2354-69. PubMed ID: 26604281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Scope of HbA1c Variability and Risk of Vascular Complications Among Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Prospective Studies.
    Guo K; Zhao Q; Wang M; Lu Y; Wo M; Zhou X; Ying C
    Horm Metab Res; 2022 Feb; 54(2):94-103. PubMed ID: 35130570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of visit-to-visit glycemic variability with risk of cardiovascular diseases in high-risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial.
    Sato M; Inaishi J; Saisho Y; Sato Y; Komuro I; Itoh H
    J Diabetes Investig; 2021 Dec; 12(12):2190-2196. PubMed ID: 34013644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between the Variability of Glycated Hemoglobin and Retinopathy in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis.
    Zhai L; Lu J; Cao X; Zhang J; Yin Y; Tian H
    Horm Metab Res; 2023 Feb; 55(2):103-113. PubMed ID: 36223803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes.
    Lu J; Wang C; Cai J; Shen Y; Chen L; Zhang L; Lu W; Zhu W; Hu G; Xia T; Zhou J
    J Clin Endocrinol Metab; 2021 Oct; 106(11):3160-3167. PubMed ID: 34279663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term HbA1c variability and macro-/micro-vascular complications in type 2 diabetes mellitus: a meta-analysis update.
    Sartore G; Ragazzi E; Caprino R; Lapolla A
    Acta Diabetol; 2023 Jun; 60(6):721-738. PubMed ID: 36715767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Glycemic Variability and Risk of Cardiovascular Events in Type 2 Diabetes: A Meta-Analysis.
    Wang T; Zhang X; Liu J
    Horm Metab Res; 2022 Feb; 54(2):84-93. PubMed ID: 35130569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study.
    Pei J; Wang X; Pei Z; Hu X
    Cardiovasc Diabetol; 2023 Oct; 22(1):287. PubMed ID: 37891565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Long-Term HbA1c Variability and Functional Limitation in Individuals Aged Over 50 Years: A Retrospective Cohort Study.
    Shao D; Wang SS; Sun JW; Wang HP; Sun Q
    Front Endocrinol (Lausanne); 2022; 13():847348. PubMed ID: 35574024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term glycemic variability and risk of adverse health outcomes in patients with diabetes: A systematic review and meta-analysis of cohort studies.
    Chen J; Yi Q; Wang Y; Wang J; Yu H; Zhang J; Hu M; Xu J; Wu Z; Hou L; Zhang Z; Zhang Y; Wang Y; Tu Z; Yang K; Guo K; Zhou Y; Geng T; Pan X; Liu G; Song P; Pan A
    Diabetes Res Clin Pract; 2022 Oct; 192():110085. PubMed ID: 36126799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher glucose fluctuation is associated with a higher risk of cardiovascular disease: Insights from pooled results among patients with diabetes.
    Li F; Zhang L; Shen Y; Liu HH; Zhang ZY; Hu G; Wang RX
    J Diabetes; 2023 May; 15(5):368-381. PubMed ID: 37070713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of Glycemic Variability in Diabetes Mellitus.
    Kusunoki Y; Konishi K; Tsunoda T; Koyama H
    Intern Med; 2022 Feb; 61(3):281-290. PubMed ID: 34544956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HbA1c Variability and the Risk of Dementia in Patients with Diabetes: A Meta-Analysis.
    Song J; Bai H; Xu H; Xing Y; Chen S
    Int J Clin Pract; 2022; 2022():7706330. PubMed ID: 35685543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated hemoglobin A1C level and the risk of diabetic retinopathy in Africa: A systematic review and meta-analysis.
    Shiferaw WS; Akalu TY; Desta M; Kassie AM; Petrucka PM; Assefa HK; Aynalem YA
    Diabetes Metab Syndr; 2020; 14(6):1941-1949. PubMed ID: 33039936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis.
    Cavero-Redondo I; Peleteiro B; Álvarez-Bueno C; Rodriguez-Artalejo F; Martínez-Vizcaíno V
    BMJ Open; 2017 Jul; 7(7):e015949. PubMed ID: 28760792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring.
    Yapanis M; James S; Craig ME; O'Neal D; Ekinci EI
    J Clin Endocrinol Metab; 2022 May; 107(6):e2221-e2236. PubMed ID: 35094087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c.
    Sun B; Gao Y; He F; Liu Z; Zhou J; Wang X; Zhang W
    Front Public Health; 2022; 10():1052485. PubMed ID: 36438253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term Glycemic Variability and Its Association With Macrovascular and Microvascular Complications in Patients With Diabetes.
    Psoma O; Makris M; Tselepis A; Tsimihodimos V
    J Diabetes Sci Technol; 2024 Jul; 18(4):956-967. PubMed ID: 36576014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Glycemic Control With Reduced Risk for Large-Vessel Disease After More Than 50 Years of Type 1 Diabetes.
    Tinsley LJ; Kupelian V; D'Eon SA; Pober D; Sun JK; King GL; Keenan HA
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3704-3711. PubMed ID: 28973526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.